Searched over 200M research papers
10 papers analyzed
These studies suggest that psilocybin is generally safe and effective for treating various mental health conditions when administered in controlled clinical environments, with no significant short- or long-term negative effects on cognitive or emotional functioning.
16 papers analyzed
20 papers analyzed
Psilocybin, a psychoactive compound found in certain mushrooms, has garnered attention for its potential therapeutic effects, particularly in mental health treatment. However, the safety profile of psilocybin, especially when administered in controlled clinical settings, is a critical aspect that requires thorough examination.
The synthesis of research findings indicates that psilocybin, when administered under medical supervision in controlled clinical settings, is generally safe and well-tolerated. Adverse effects are typically mild, transient, and manageable. The safety profile of psilocybin, coupled with its potential therapeutic benefits for various mental health conditions, supports further research into its clinical applications. However, it is important to note that these conclusions are based on controlled environments, and the safety of psilocybin outside such settings, particularly in recreational use, may differ.
Most relevant research papers on this topic